The U.S. veterinary infectious disease diagnostics market is set for robust growth from 2025 to 2035, driven by increasing demand for rapid, reliable disease detection in companion animals and livestock. Veterinary infectious disease diagnostics—including consumables, reagents, kits, equipment, and instruments—play a critical role in identifying bacterial, viral, and parasitic infections. These tools are essential for veterinary hospitals, clinics, and reference laboratories, ensuring timely treatment, herd health management, and zoonotic disease prevention. This report provides insights into market size, key growth drivers, technology trends, and strategic implications for stakeholders in the U.S.
Market Size and Growth
The U.S. veterinary infectious disease diagnostics market is projected to grow from approximately USD 2.64 billion in 2025 to USD 6.28 billion by 2035, reflecting a CAGR of 9.1%. This growth is fueled by rising pet ownership, increasing livestock production, and expanding adoption of advanced diagnostic technologies in veterinary practices. Consumables, reagents, and kits are expected to dominate the market with a 58% share, while companion animal applications will lead the animal segment, accounting for 55% of demand.
To access the complete data tables and in-depth insights, request a Discount On The Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=12266
Key Growth Drivers
Rising demand for rapid and accurate diagnostics: Veterinary practitioners and livestock producers are increasingly adopting high-sensitivity assays and point-of-care testing to enable swift and precise disease identification.
Technological innovation: Molecular diagnostics, immunodiagnostics, PCR, ELISA, and lateral flow assays enhance detection accuracy, reduce turnaround times, and support multiplex testing for multiple pathogens simultaneously.
Expansion of veterinary services: Growth in veterinary clinics, reference laboratories, and livestock testing facilities in the U.S. enhances market penetration and adoption of advanced diagnostic solutions.
One Health initiatives: Increased focus on zoonotic disease monitoring and food safety surveillance drives adoption of veterinary diagnostics in public health programs.
Technology Trends and Competition
The U.S. market is competitive, featuring prominent players such as IDEXX Laboratories Inc., Zoetis Services LLC, Thermo Fisher Scientific Inc., Virbac, bioMérieux SA, Neogen Corporation, and Bio-Rad Laboratories. Key technology trends include:
- Point-of-care testing platforms enabling rapid diagnostics in-clinic.
- Multiplex PCR and ELISA-based assays for simultaneous detection of multiple pathogens.
- Integration with practice management software for streamlined workflows and data-driven decision-making.
- Portable and user-friendly instruments for both companion animal and livestock applications.
Challenges
Despite strong growth, the market faces challenges such as fluctuating costs of advanced molecular assays, limited veterinary diagnostic infrastructure in rural areas, regulatory approval requirements, and supply chain complexities for reagents and kits. These factors may slow adoption among smaller veterinary practices and emerging regions within the U.S.
Strategic Implications
For manufacturers: Focus on developing cost-effective, high-sensitivity assays, and invest in molecular and multiplex diagnostic innovations. Partnerships with veterinary hospitals, livestock producers, and reference laboratories will strengthen market presence.
For veterinary providers: Incorporate comprehensive infectious disease diagnostics into preventive medicine programs, herd health protocols, and therapeutic decision-making processes.
For investors: The market offers attractive growth potential with a strong CAGR, driven by rising companion animal care, livestock production, and regulatory support for disease monitoring initiatives.
Outlook Summary
From 2025 to 2035, the U.S. veterinary infectious disease diagnostics market is expected to experience substantial growth, with companion animal applications and consumables, reagents, and kits leading demand. Technological advancements, increasing preventive care initiatives, and One Health-oriented disease surveillance will drive market expansion. While challenges like cost fluctuations and infrastructure limitations exist, the sector presents promising opportunities for manufacturers, veterinary service providers, and investors committed to improving animal health outcomes and supporting public health initiatives.
Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us – [email protected]
About Fact.MR
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.
